OSTEEN DEBRA K
Known title: Chief Executive OfficerCIK: 0001181035
Associated companies
Transaction History
| ACHC | ▼ Sell | Open Market | 35,000 | $2.7M | 12/13/2023 | View on chart |
| ACHC | ▼ Sell | Open Market | 8,000 | $610K | 12/12/2023 | View on chart |
| ACHC | ▼ Sell | Open Market | 15,000 | $1.1M | 11/8/2023 | View on chart |
| ACHC | ▲ Buy | Grant | 2,229 | $0 | 5/18/2023 | View on chart |
| ACHC | ▲ Buy | Grant | 614,418 | $0 | 2/21/2023 | View on chart |
| ACHC | ▼ Sell | Tax Withholding | 241,773 | $19.6M | 2/21/2023 | View on chart |
| ACHC | ▲ Buy | Grant | 2,303 | $0 | 5/19/2022 | View on chart |
| ACHC | ▲ Buy | Grant | 131,016 | $0 | 2/25/2022 | View on chart |
| ACHC | ▲ Buy | Grant | 169,050 | $0 | 2/25/2022 | View on chart |
| ACHC | ▼ Sell | Tax Withholding | 118,075 | $6.7M | 2/25/2022 | View on chart |
| ACHC | ▼ Sell | Tax Withholding | 27,403 | $1.4M | 1/31/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Acadia Healthcare Sets Q3 2026 Earnings Date
Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.
Acadia Healthcare Sets Q3 2026 Earnings Date. Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.